MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A Conversational GPT Agent for Parkinson’s Disease

    B. Várkuti, L. Manola, M. Atayi, L. Liemen, G. van Elswijk, F. Lange, M. Reich, L. Erōss, M. Okun, J. Volkmann (München, Germany)

    Objective: To create a conversational chat agent that can provide persons with Parkinson’s with information about their disease. Background: Artificial intelligence using Large Language Models…
  • 2024 International Congress

    Wearable Device for Real-Time Prevention of Freezing-of-Gait in Parkinson’s Disease

    A. Alakhras, S. Pardoel, E. Jafari, J. Kofman, E. Lemaire, J. Nantel (Ottawa, Canada)

    Objective: In our previous work, we developed machine learning models to predict and detect freezing-of-gait (FOG) [1]. In this study, we aimed to use those…
  • 2024 International Congress

    How many days are required to reliably estimate diverse digital mobility outcomes from various gait domains with a lower back sensor in people with Parkinson’s disease?

    E. Gazit, J. Garcia-Aymerich, J. Buekers, S. Del Din, A. Mueller, W. Maetzler, A. Yarnall, C. Schlenstedt, A. Nieuwboer, A. Mirelman, H. Gassner, D. Singleton, B. Vereijken, L. Rochester, JM. Hausdorff (Tel aviv, Israel)

    Objective: To determine the  number of days needed to obtain reliable, diverse digital mobility outcomes (DMOs) from daily activity recordings obtained using a lower back,…
  • 2024 International Congress

    Examining and contextualizing free-living heart rate using multiple wearable sensors: a potential approach for assessing autonomic dysfunction in Parkinson’s disease?

    FE. Godkin, K. van Ooteghem, K. Ehgoetz Martens, K. Weber, B. Cornish, K. Beyer, D. Olszewska, C. Fearon, A. Lang, R. Swartz, M. Masellis, B. Tan, J. Tung, A. Roberts, W. Mcilroy (Waterloo, Canada)

    Objective: To examine context-specific fluctuations in free-living heart rate (HR) across a week-long multi-sensor wear period in people with Parkinson’s disease (PD). Background: Non-motor symptoms,…
  • 2024 International Congress

    Medication Effects on Bradykinesia and Tremor in Parkinson’s Disease, Measured by Wearable Sensors

    R. Weijer, A. Szanto, V. Exadaktylos, J. van Hilten, D. Hepp (Leiden, Netherlands)

    Objective: To determine the responsiveness to the effects of medication of home based unsupervised wearable sensor assessed tests for the evaluation of bradykinesia and tremor…
  • 2024 International Congress

    Spinocerebellar ataxia type 2 (SCA2) and Seizures: Is There a Correlation?

    P. Bhatia, S. Kaur (Phoenix, USA)

    Objective: We describe 3 patients of SCA2 with seizures, a rare phenomenology. Background: Spinocerebellar ataxia (SCA) is a heterogenous group of autosomal dominant neurodegenerative ataxic…
  • 2024 International Congress

    Ataxia Telangiectasia Diagnosis in Lower-Middle-Income Countries: A Case Report

    H. Ngo Thi, T. Nguyen Anh (Hanoi, Viet Nam)

    Objective: to describe clinical features and diagnostic tests in a patient with Ataxia Telangiectasia (AT) in Vietnam. Background: AT is a rare hereditary syndrome, the…
  • 2024 International Congress

    Evaluating Pharmacological Interventions for Friedreich Ataxia: A Network Meta-Analysis of Randomised Trials

    T. Dave, V. Kumar, R. Raj, MA. Shamim, V. Suresh, K. Patel, M. Hassan, A. Bhonsale, DVV. Krishna, B. Dhakal, A. Ambulinambi, D. Dey (Chernivtsi, Ukraine)

    Objective: To compare the clinical efficacy of different pharmacological agents in reduction of disease severity of Friedreich Ataxia. Background: Friedreich ataxia is a rare, inherited,…
  • 2024 International Congress

    Volatile solvent abuse and Cerebellar ataxia: A case series

    J. Ganguly, S. Jha, N. Pandita, S. Mukherjee, N. Singh, H. Kumar (Kolkata, India)

    Objective: Delineation of clinical and radiological features of cerebellar ataxia from volatile solvent abuse. Background: Volatile solvents like glues, correction fluid, acrylic paints, varnishes, lacquers…
  • 2024 International Congress

    Challenges of Huntington’s disease and chorea in Guinea: the benefits of genetic testing in tropical environments

    G. Carlos Othon, A. Agsha, H. Lee, M. Rizig, A. Cisse (Conakry, Guinea)

    Objective: The aim of this study was to identify the genetic underlier of individuals presenting with chorea, allowing for the diagnosis of these patients, and…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley